Roopan Aulakh

Helex is taking the promise of non-viral targeted delivery and genome editing to the kidney, developing first-in-class genetic medicines for renal indications. Helex combines its proprietary kidney tropic lipid nanoparticle delivery system with the Epic-Cure(TM) 3D genome-based drug designer platform to create a robust renal franchise of precise and scalable therapeutics. Our lead asset is a mutation-agnostic, potential one-and-done therapy for Autosomal Dominant Polycystic Kidney Disease that impacts over 4 million people worldwide.

Ahammune Biosciences Pvt. Ltd. is a startup company based in Pune. Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo. The current treatments for Vitiligo provide only temporary and symptomatic relief. Thus, there is an enormous unmet global need in treating patients with Vitiligo. The mission of Ahammune Biosciences is to arrest the progress of Vitiligo and to induce re-pigmentation of depigmented patches. We are committed to take our innovation-driven drug discovery platform to the next level to demonstrate to the world that we as a nation can foster new molecules for complex diseases.

We help you continuously red-team your GenAI applications against ever-evolving AI threat landscape.

3D reality capture and analytics for the built environment. Digitize your properties, effectively track progress and never miss a detail with our fast, easy-to-use and integrable application. Book a demo at www.preimage.ai/schedule-a-demo

Network of Autonomous Delivery Robots

We perform Antibody Discovery using Artificial Intelligence. Job Openings: https://www.immunitoai.com/job-openings Our Team: https://www.immunitoai.com/about-us YouTube Channel: https://www.youtube.com/@immunitoAI

Ai Palette is creating a world where AI is used to discover, launch and grow consumer products in the CPG Industry. With its patented technology along with the worlds largest CPG data lake of 61 Billion data points, AI Palette Platform offers consumer insights in 18 languages across 27 countries in 6 continents to create products that truly resonate with consumer needs. Headquartered in Singapore, Ai Palette is a trusted innovation partner to some of the world’s largest CPG companies, including Nestlé, Mondelez, Diageo, OFI, and Himalayas, driving both innovation and product renovation on a global scale.

Pixis is a complete, AI-powered advertising solution helping consumer brands improve ad performance and streamline workflows.

At AgniKul, we design, manufacture, test and launch orbital class rockets for micro and nano satellites. We currently work out of the National Center for Combustion R&D at IIT-Madras. Rocket scientists, engineers, ex-bankers and space lawyers are a part of our team. This unique blend of people is one of our biggest strengths. Our goal is to make space affordable for everyone in India. If you are excited about our journey, please reach out to us @ humancapital@agnikul.in & follow us on twitter. https://twitter.com/AgnikulCosmos

Wysa is an AI-enabled Coach for mental and emotional wellness. Launched in 2016, Wysa provides early intervention via its AI chatbot, library of evidence-based self-help tools, and messaging-based support from human coaches. Anonymous, empathetic and available 24x7, Wysa covers 11 million lives, and has helped over 6 million people in 95 countries through 500+ million conversations. Wysa is a global leader in digital mental health, rated 93% by ORCHA, the digital health app evaluation agency used by the NHS, with a 100% on clinical assurance; and recommended by the NHS. Google has featured Wysa twice as their top mental health app on Google Play for World Mental Health Day 2018 and 19. Wysa has also been showcased at forums like The World Economic Forum, Apple Entrepreneurship Camp, Philips Health Works, and Swiss Re’s Insurtech incubator program. Visit www.wysa.com to find out more and request a demo for your workplace today.

We are the $3B diversified venture capital fund of Aramco Ventures, a subsidiary of Aramco. We invest globally in startups with a long-term view. We support the development of next-generation technologies and business models that will bring prosperity and positive impact on a vast scale. Our lineage of explorers and entrepreneurs influences everything we do. Our history is built on taking big ideas and turning them into big realities. Our name references the first well to strike oil in Saudi Arabia after six attempts. Prosperity Well, the seventh well, was the largest oil find in the world. This find and ensuing development transformed the lives of generations and has enabled growth and prosperity around the world. As dedicated long-term partners to our entrepreneurs and companies, we move quickly as we support their growth and success. At Prosperity7 Ventures we partner with today’s pioneers and explorers to enable continued global growth and transformation.

Helex is taking the promise of non-viral targeted delivery and genome editing to the kidney, developing first-in-class genetic medicines for renal indications. Helex combines its proprietary kidney tropic lipid nanoparticle delivery system with the Epic-Cure(TM) 3D genome-based drug designer platform to create a robust renal franchise of precise and scalable therapeutics. Our lead asset is a mutation-agnostic, potential one-and-done therapy for Autosomal Dominant Polycystic Kidney Disease that impacts over 4 million people worldwide.

Ahammune Biosciences Pvt. Ltd. is a startup company based in Pune. Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo. The current treatments for Vitiligo provide only temporary and symptomatic relief. Thus, there is an enormous unmet global need in treating patients with Vitiligo. The mission of Ahammune Biosciences is to arrest the progress of Vitiligo and to induce re-pigmentation of depigmented patches. We are committed to take our innovation-driven drug discovery platform to the next level to demonstrate to the world that we as a nation can foster new molecules for complex diseases.

We help you continuously red-team your GenAI applications against ever-evolving AI threat landscape.

3D reality capture and analytics for the built environment. Digitize your properties, effectively track progress and never miss a detail with our fast, easy-to-use and integrable application. Book a demo at www.preimage.ai/schedule-a-demo